LA JOLLA—For most people, the urge to eat a meal or snack comes at a few, predictable times during the waking part of the day. But for those with a rare syndrome, hunger comes at unwanted hours, interrupts sleep and causes overeating.
LA JOLLA—The Salk Institute has received a $3 million gift from the Glenn Foundation for Medical Research to allow the Institute to continue conducting research to understand the biology of normal human aging and age-related diseases.
LA JOLLA—The Salk Institute’s award-winning Education Outreach program recently earned national recognition when it received a two-year pilot grant through the AAAS’s new National STEM (Science, Technology, Engineering and Math) Volunteer Program. The grant, one of just seven the association awarded, will help bring San Diego-area high school science teachers together with Salk scientists to develop curriculum based on the state-of-the-art research taking place at the Institute.
LA JOLLA—Using new stem cell technology, scientists at the Salk Institute have shown that neurons generated from the skin cells of people with schizophrenia behave strangely in early developmental stages, providing a hint as to ways to detect and potentially treat the disease early.
LA JOLLA—By carefully controlling the levels of two proteins, researchers at the Salk Institute have discovered how to keep mammary stem cells—those that can form breast tissue—alive and functioning in the lab. The new ability to propagate mammary stem cells is allowing them to study both breast development and the formation of breast cancers.
LA JOLLA—Scientists at the Salk Institute have discovered the developmental source for a key type of neuron that allows animals to walk, a finding that could help pave the way for new therapies for spinal cord injuries or other motor impairments related to disease.
LA JOLLA—Scientists at the Salk Institute for Biological Studies have identified a key genetic switch linked to the development, progression and outcome of cancer, a finding that may lead to new targets for cancer therapies.
LA JOLLA—The American Academy of Arts and Sciences (AAAS) elected Salk Professor Geoffrey M. Wahl to its society, whose ranks include Nobel laureates, Pulitzer Prize recipients and Oscar winners, as well intellectual luminaries such as George Washington, Benjamin Franklin and Albert Einstein. Wahl joins 13 other Salk professors as members into the prestigious AAAS.
LA JOLLA—Using reprogrammed skin cells, researchers have for the first time used stem cell techniques to grow fully functional assemblies of the cells that line airways leading to the lungs. The lab-grown airway tissue can now be used to study the molecular basis for lung diseases—from rare genetic disorders to common afflictions like asthma and emphysema—and test new drugs to treat the diseases.
LA JOLLA—The Salk Institute is pleased to announce the appointment of longtime San Diego real estate developer and community builder, Donald Cohn, to its Board of Trustees.
LA JOLLA—By discovering a new mechanism that allows blood to enter the brain immediately after stroke, researchers from the Salk Institute and University of California (UC) Irvine reveal a possible means to create new therapies that may reduce or prevent stroke-induced damage in the brain.
LA JOLLA—Scientists at the Salk Institute have created a new model of memory that explains how neurons retain select memories a few hours after an event.
LA JOLLA—Reuben Shaw, a member of the Salk Institute’s Molecular and Cell Biology Laboratory and a Howard Hughes Medical Institute early career scientist, has been promoted from associate professor to full professor.
After a rigorous evaluation process by Salk senior faculty, nonresident fellows and scientific peers, the promotion was announced Friday.
LA JOLLA—Scientists at the Salk Institute have uncovered details into a surprising—and crucial—link between brain development and a gene whose mutation is tied to breast and ovarian cancer. Aside from better understanding neurological damage associated in a small percentage of people susceptible to breast cancers, the new work also helps to better understand the evolution of the brain.
LA JOLLA—Janelle Ayres, assistant professor at Salk Institute’s Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis, has received the prestigious Searle Scholar award, which each year is given to only 15 researchers in the fields of chemical and biological sciences.
LA JOLLA—Vicki Lundblad, professor of the Salk Institute’s Molecular and Cell Biology Laboratory, has been awarded the Becky and Ralph S. O’Connor Chair and elected a Fellow of the American Academy of Microbiology.
LA JOLLA — A new science outreach program promotes virtual interaction and learning between Salk Institute scientists and students at the Del Mar Hills Academy of Arts and Sciences in Del Mar, California.
LA JOLLA—The Salk Institute for Biological Studies will join Stanford University in leading a new Center of Excellence in Stem Cell Genomics, created through a $40 million award by California’s stem cell agency, the California Institute for Regenerative Medicine.
LA JOLLA—A chemical that’s found in fruits and vegetables from strawberries to cucumbers appears to stop memory loss that accompanies Alzheimer’s disease in mice, scientists at the Salk Institute for Biological Studies have discovered. In experiments on mice that normally develop Alzheimer’s symptoms less than a year after birth, a daily dose of the compound—a flavonol called fisetin—prevented the progressive memory and learning impairments. The drug, however, did not alter the formation of amyloid plaques in the brain, accumulations of proteins which are commonly blamed for Alzheimer’s disease. The new finding suggests a way to treat Alzheimer’s symptoms independently of targeting amyloid plaques.
LA JOLLA, CA—Highly diverse cancers share one trait: the capacity for endless cell division. Unregulated growth is due in large part to the fact that tumor cells can rebuild protective ends of their chromosomes, which are made of repeated DNA sequences and proteins. Normally, cell division halts once these structures, called telomeres, wear down. But cancer cells keep on going by deploying one of two strategies to reconstruct telomeres.
